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Perforin-(P-) related characteristics of cytotoxic T lymphocytes and natural killer cells were investigated in peripheral blood of
p a t i e n t ss u b j e c t e dt oo p e n( O C ;n = 23) or laparoscopic cholecystectomy (LC; n = 21) and healthy controls (n = 20). Blood
sampleswereobtainedpreoperatively and24hoursafterthesurgeries,andthedatawerecorrelatedwiththeintensityofcholestasis
and concomitant inﬂammation, determined by functional hepatic tests. Postoperative diﬀerences were found to be minimal:
OC decreased only the percentage of CD56+ cells, while LC decreased the fraction of CD8+P
+ cells and augmented the mean
ﬂuorescence intensity of P in CD56 cells. Patients elected for OC had, however, higher preoperative numbers of total P
+,C D 3 +P
+,
and CD4+P
+ cells than patients elected for LC and healthy controls, while both groups of patients, preoperatively, had lower
fraction of CD16+P
+ and CD56+P
+ cells. These changes were in high correlation with blood concentrations of CRP, AP, and ALT,
emphasizing the link between the preoperative cholestasis and inﬂammation and P-dependent cytotoxic mechanisms.
Copyright © 2009 Harry Grbas et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
1.Introduction
Since its introduction in the late 1980s, laparoscopic chole-
cystectomy (LC) has been used as a “gold standard” for man-
agement of symptomatic gallstone disease, replacing almost
completely the open cholecystectomy (OC) [1–3]. It is
commonly followed by less pain, shorter hospitalization, and
faster recovery owing to the reduced magnitude of the initial
surgical insult and lower systemic immune impairment
[4]. However, positive CO2 pneumoperitoneum, abdominal
wall distention, and peritoneal acidosis may activate the
additional factors that aﬀect the outcome of operations,
leading to both the potentiation of surgical trauma [4, 5],
and the beneﬁcial immune-modulating eﬀect, linked with
the augmentation of IL-10, attenuation of TNFα production
[6–8], and diminishing eﬀect on surgery-induced imbalance
in pro-/anti-inﬂammatory cytokines [9, 10]. Cellular mech-
anisms underlying these eﬀects are, however, very complex,
since surgical manipulation or pneumoperitoneum and
laparotomy may alter the expression of 116 and 398 splenic
T-cell genes, respectively, that might be involved in signal
transduction,chemotaxis,andcellcycleoflymphocytes[11].
In the present study, we tried to analyze the perioperative
changesincytotoxicTlymphocytes(CTLs)andnaturalkiller
(NK) cells after LC and OC, since, particularly, these cells are
involved in immune surveillance and have the crucial roles
in the prevention or attenuation of disease through their
ability to eliminate infected or transformed cells [12–15].
Their cytoplasm is rich in granules composed of complexes
of proteoglycan in association with the pore-forming protein
perforin (P) and a family of serine proteinases, known
as granzymes that are released into the intercellular space
on interaction of NK cells or CTL with a target cell.
Whether granzyme entry into the target cell cytoplasm
occurs directly after perforin pore formation in the plasma
membrane or after endosomolysis is still debated [12–15].
According to the original model, P acts by forming a cell
membrane pore through which granzymes pass into the
target cell, where they cleave speciﬁc substrates that initiate
DNA fragmentation and caspase-dependent or caspase-
independent apoptotic cell death. However, more recently,
it was proposed that granzymes might be endocytosed
independently of P and that P acts to release granzymes
that are sequestered in endosomes into the cytosol of2 Mediators of Inﬂammation
Table 1: Demographic and surgery-related data in patient groups for classic and laparoscopic cholecystectomy.
Classic cholecystectomy P Laparoscopic cholecystectomy
Number of patients 23 — 21
Ratio Female/male 13/10 — 13/8
Age-mean (min-max) 61.8 (31–85) 0.23n.s. 55.5 (28–82)
Duration of anesthesia (min) 90 (74–130) 0.38n.s. 120 (90–150)
Duration of operation (min) 65 (35–120) 0.45n.s. 90 (40–150)
the target cell. In addition, there is a possibility that P
triggers Ca2+ inﬂux, which may activate rapid coendocy-
tosis of granzymes and P into giant endosomes, followed
by P-mediated release of granzymes to the cytosol [12–
15].
In circulating nonactivated lymphocytes, cytotoxicity is
restricted to NK cells, γ/δ TCR+ T cells, and a subpop-
ulation of CD8+ cells, which constitutively express per-
forin but its expression can be induced in many CD4+,
MHC class II restricted CTL, in CD8+ C T La sw e l la si n
CD4lowCD25highFoxP3+ Tr e g u l a t o r yc e l l s[ 12–15]. More-
over, the expression of P in T cells might be a useful marker
for functionally activated cytotoxic cells in situ [12].
Trying to determine the early postoperative eﬀects of
classic and laparoscopic cholecystectomy on these events,
in this study we analyzed the P content in the PBMNLC
before and 24 hours after the operations. Furthermore, in an
attempttolinktheseeventswiththeintensityofpreoperative
cholestasis and inﬂammation induced by gallstones, we
correlated these data with the blood concentrations of acute
phase proteins and markers of cholestasis, such as bilirubin
(BIL), alkaline phosphatase (AP), and hepatic enzymes. The
data showed that perforin-dependent cytotoxic mechanisms
are only moderately aﬀected by diﬀerent types of operations,
but that the preoperative cholestasis and hepatic injury may
signiﬁcantly increase the number of peripheral blood cells
containing the perforin.
2. Patientsand Methods
2.1. Patients. In a prospective, nonrandomized study that
was approved by Ethical Committee of Medical faculty,
University of Rijeka, we analyzed the immune functions
of 23 patients submitted to conventional, open cholecys-
tectomy (OC) and 21 patients undergoing laparoscopic
cholecystectomy (LC) for symptomatic cholecystolithiasis.
Mean age for the conventional group was 61.8 years (range
31 to 85) for 13 women and 10 men. For LC, mean age
was 55.5 years (range 28 to 82); this group consisted of
13 women and 8 men. Laparoscopic cholecystectomy was
carried out in a standardized technique using 4 troacars and
a pneumoperitoneum of 14mmHg. Open cholecystectomy
was performed through a right subcostal incision. General
anesthesia was the same in both groups. Mean operative
duration was 90 minutes (range 74–139) for OC and
120 minutes (range 90–150), for LC without statistically
signiﬁcant diﬀerence, showing that the two groups were
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Figure 1: Preoperative values of total bilirubin, enzyme tests (alka-
line phosphatase-AP, gamma-glutamyl transferase-GGT, aspar-
tat aminotransferase-AST, alanine aminotransferase-ALT and C-
reactive protein-CRP in sera of patients chosen for classic or
laparoscopic cholecystectomy. o P <. 05, oo P <. 01.
comparableforthedemographicandsurgery-relatedparam-
eters (Table 1).
There were also no statistically signiﬁcant diﬀerences
in the standard hematological parameters, such as red and
white cells counts, hematocrit, and platelets (not shown)
but group of patients chosen for classic cholecystectomy
had signiﬁcantly greater preoperative cholestasis (Figure 1),
sincelaparoscopiccholecystectomywithinsuﬄationsofCO2
was avoided in patients with chronic cholecystolithiasis.
Therefore, this group of patients had signiﬁcantly higher
levels of total bilirubin (57.6 versus 13.1μmol/L, P<
.04), AP (216.4 versus 64.0IU/L; P<. 02), GGT 273.03
versus 28.96IU/L; P<. 004), AST (56.3 versus 24.4; P<
.05), ALT (95.42 versus 28.9IU/L; P<. 009), as well as
the higher levels of CRP (28.57 versus 4,84mg/L; P<
.003) in comparison with group chosen for laparoscopic
cholecystectomy.
In both groups, the patients with acquired or inherited
immunodeﬁciencies and those who developed postoperative
complications were excluded from the study. Blood samples
were collected preoperatively and on postoperative day 1
andtestedforhematologicalandimmunologicalparameters.
Twenty healthy persons, consisting of laboratory personnel
and blood volunteer donors (10 females and 10 males),
corresponding by age and sexes to the examined patients
groups were also studied.Mediators of Inﬂammation 3
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Figure 2: Percentage of surface marker positive T lymphocytes (a)
and NK cells (b) (mean percentage ± S.E.M.) in peripheral blood
from patients subjected to classic or laparoscopic cholecystectomy
before (two-colored columns) and after operation (one-colored
column). ∗Statistical signiﬁcance between the preoperative and
postoperative values ∗P <. 05.
2.2. Lymphocyte Preparation. Heparinized venous blood
(10mL) was diluted and separated on Lymphoprep
(Nycomed Pharmaas, Oslo, Norway) for 20 minutes on 800
G. Cells accumulating at the interface were washed twice
in RPMI 1640 and resuspended at a ﬁnal concentration
of 1 × 106 peripheral blood lymphocytes per sample in
ﬂuorescent-activated cell sorting (FACS) buﬀer. Viability
was assessed by trypan blue and was always around 98%.
2.3. Monoclonal Antibodies (MoAbs). For staining of sur-
face markers on human T and NK cells, the following
phycoerythrin-(PE)- conjugated MoAb, obtained from Bec-
ton Dickinson (Mountain View) were used: anti-CD3, anti-
CD4, anti-CD8, anti-CD16, and anti-CD56). For the detec-
tion of intracellular perforin a murine antihuman perforin
MoAb δG9 (MoAb; IgG2b) was puriﬁed from Balb/c ascites
[16].
2.4. Simultaneous Measurement of Cell Surface (CD Markers)
and Intracellular Antigen (Perforin) by Flow Cytometry.
The method for the simultaneous detection of perforin
(intracellular antigen) and cell surface antigens is described
in detail elsewhere [17]. Brieﬂy, peripheral blood mononu-
clear cells (PBMNLC) were aliquoted (106 per aliquot)
and washed in FACS buﬀer, then ﬁxed in 100μL PBS
containing 4% paraformaldehyde, pH 7.4, for 10 min-
utes at room temperature. After two washes in FACS
buﬀer, the cells were permeabilized with saponin buﬀer
(0.1% saponin) (Sigma, Poole, Dorset) for 20 min at
room temperature. Murine monoclonal antibody reacting
with human perforin (P) MoAb-G9 (IgG2b, puriﬁed from
Balb/c ascites) was added to the suspension of cells in
saponin, at ﬁnal concentration of 8–10μg per sample
and incubated for 30 minutes at room temperature. All
further steps, secondary antibody, FITC-conjugated goat-
antimouse Ig (Becton Dickinson, San Jose, Calif, USA),
and rising procedures were performed in Saponin buﬀer.
Cells surface antigens (CD3, CD4, CD8, CD16, and CD56)
were then stained in FACS buﬀer at a ﬁnal concentration
of monoclonal antibody of 10μg/mL (Becton Dickinson)
and 100μL were added to the pelleted cells. After 30-
minutes incubation at +4◦C ,c e l l sw e r ew a s h e dw i t hF A C S
buﬀer and stained with avidin-phycoerythrin (20μg/mL,
Becton Dickinson) for 30 min. An irrelevant isotype-
matched murine MoAb was used as a negative control. A
minimum of 104 cells was analyzed on FACScan (Becton
Dickinson).
2.5. Liver Functional Tests. The standard preoperative
workup for predicting choledocholithiasis in both group
of patients included liver function tests and abdom-
inal ultrasound. Liver transaminases (ALT, AST), liver
cholestasis tests (gamma-glutamyl transpeptidase-GGT, and
alkaline phosphatase-ALP) and liver clearance tests (total
and conjugated bilirubin-BIL) were determined by enzy-
matic calorimetric methods, using routine laboratory tech-
niques with Roche reagents in a Roche-Hitachi Modular-
P800 clinical chemistry module (Roche, Mannhein, Ger-
many).
2.6.StatisticalAnalysis. Statisticalsigniﬁcancewascalculated
by two-tailed Student’s t-test for paired samples, and by
Mann-Whitney U-test for the evaluation of diﬀerences
between the groups. Test of correlation and linear regression
analyses were made by statistical software Statistics for
Windows, Kernel release 5.5 (StatSoft, Inc., Tulsa, OK).
Linear regression equations were generated using a Pearson-
Product moment correlation and analyzed for diﬀerences
of covariance. P values of .05 or less were considered
statistically signiﬁcant. Data are reported as mean ± SEM
or as median values, with 25th–75th percentiles in parenthe-
ses.
3. Results
Immune status of patients undergoing classic, open (OC),
or laparoscopic (LC) cholecystectomy was evaluated before
and 24 hours after the operations. Comparison of the data
was then made between the pre- and postoperative values4 Mediators of Inﬂammation
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Figure 3: Percentage of total number of perforin positive cells (TPs) and double positive (perforin positive (P+)a n ds u rf a c em a rk e rpo s i ti v e )
Tl y m p h o c y t e s( a )o rN Kc e l l s( b )( m e a np e r c e n t a g e± S.E.M.) in peripheral blood from patients subjected to classic or laparoscopic
cholecystectomy before (two-colored columns) and after operation (one-colored column) compared to healthy control (ﬁrst, blue column).
O-statistical signiﬁcance toward healthy control; X-statistical signiﬁcance between the preoperative values in classic and laparoscopic
cholecystectomy; ∗statistical signiﬁcance between the preoperative and postoperative values in classic or laparoscopic cholecystectomy. One
mark P <. 05, two marks P <. 01, three marks P<. 001. (c) Representative ﬂow cytometric proﬁle of perforin expression on the gated CD8+
PBMNLC before (shadow area) and 24 hours after (solid line) laparoscopic cholecystectomy. Isotype control is shown as dotted line.
in the same group, between the preoperative values in the
OCa n dL Cgr o u p sa sw e lla sb e t w e e nt h ep r e o p e ra t i v ev a l u e s
in groups of patients elected for operations and the control
group, consisting of healthy blood donors of corresponding
age. Analysis included standard determination of surface
antigens on lymphatic cells and two color analysis, with
simultaneous determination of surface markers and intracel-
lular content of perforin.
3.1. Peripheral Blood Lymphocyte Subpopulations in Patients
Undergoing to Open or Laparoscopic Cholecystectomy. Stan-
dard immunological tests revealed that preoperative num-
bers of T lymphocytes (CD3+,C D 4 +, and CD8+)a n dN K
cells (CD16+and CD56+)i nb o t hg r o u p sw e r ei nn o r m a l
ranges for healthy, adult people. Furthermore, no diﬀerences
were found in preoperative values of both T (Figure 2(a))
and NK cells (Figure 2(b)) in blood of patients electedMediators of Inﬂammation 5
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Figure 4: Representative two color analysis of PBMNLC for perforin (horizontal) and cell surface phenotype (vertical) in healthy persons
and patients elected for classic cholecystectomy. (a) Subpopulations of T lymphocytes (CD3+P+ and CD4+P+); (b) subpopulation of NK
cells (CD16+P+).
for OC and LC groups as well as in the postoperative
v a l u e so fa l lTl y m p h o c y t e sa n dC D 1 6 + NK cells. Classic
cholecystectomy, however, slightly decreased the percentage
of CD56+NK cells (18.7% versus 15.4%; P<. 05), as shown
on Figure 2(b).
3.2. Perforin Positive Peripheral Blood Lymphocytes. Data
were then analyzed by double labeling of CD surface marker
and perforin and presented as a fraction of total peripheral
blood lymphocytes containing perforin (TP+ cells) and as
ap e r c e n t a g eo fd o u b l ep o s i t i v eT( Figure 3(a))o rN Kc e l l s
(Figure 3(b)).
The signiﬁcant postoperative diﬀerence was found
only after LC, which decreased the fraction of cytotoxic
CD8+P+cells from 13.5 to 10.2% (P<. 05), as it is
presented on Figure 3(a) and on representative histogram
(Figure 3(c)), showing perforin expression on the gated
CD8+T cells, before and after LC.
Comparison with healthy control revealed, however, that
preoperative values of TP+ and CD3+P+ cells in patients
elected for OC were signiﬁcantly higher than normal
values (30.78% and 16.05% versus 27.3% and 10,68%,
resp.; P<. 05) (Figure 3(a)), as well as that all patients
elected for operations had, preoperatively, lower fractions of
perforin positive NK cells (Figure 3(b)), since in OC group
CD16+P+ cell fraction fell from 20.16% to 14.14% (P<. 05)
and CD56+P+ cells from 20.74% to 13.63% (P<. 05) and in
LC group to 10.71% (P<. 05) and to 11.64% (P<. 001),
respectively.
Increased expression of perforin in T cells (CD3+P+
and CD4+P+) and lower expression of perforin in NK cells
(CD16+P+) in preoperative blood of patients elected for
classic cholecystectomy versus control subjects are presented
also by the representative density plots (Figure 4(a) and 4(b),
resp.).
3.3. Level of Perforin Protein Expression in T and NK Cell
Subsets. The procedure of double labeling of peripheral
blood lymphocytes by ﬂow cytometry permitted also the
measurement of mean ﬂuorescence intensity (MFI), which
correlates with a number of perforin molecules present in
the cells [17]. By applying standard parameters for FSC,
SSC, FL1 and FL2, we thus, analyzed MFI for perforin
in subsets of T lymphocytes (CD3+P+,C D 4 +P+,C D 8 +P+)
and NK cells (CD16+P+ and CD56+P+). As presented on
Figure 5(b) and on representative histogram (Figure 5(c))
we noticed slight upregulation of perforin content only
after LC in CD56+P+cells (P<. 05). The data, how-
ever, clearly showed that lymphatic subpopulation (CD3,
CD4, CD16 and CD56) of patients undergoing the clas-
sic cholecystectomy contained, preoperatively, the higher
quantities of perforin in their granules in comparison
with patients selected for LC (Figures 5(a), 5(b),a n d
6).6 Mediators of Inﬂammation
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Figure 5: The levels of P expression (mean ﬂuorescence intensity; MFI values) for (a) T lymphocytes (CD3+P+) and their subpopulations
(CD4+P+ and CD8+P+), and (b) NK cells (CD16+P+ and CD56+P+) in peripheral blood from patients subjected to classic or laparoscopic
cholecystectomy before (two-colored columns) and after the operation (one-colored column). O-statistical signiﬁcance between the
preoperative values in classic and laparoscopic cholecystectomy; ∗statistical signiﬁcance between the preoperative and postoperative values
in classic or laparoscopic cholecystectomy. One mark P <. 05, two marks P <. 01. (c) Representative ﬂow cytometric proﬁle of perforin
expression on the gated CD56+ PBMNLC before and 24 hours after laparoscopic cholecystectomy. The shadow area was perforin expression
while the nonshadow area was isotype control. The amount of perforin per cell is indicated by the mean ﬂuorescence intensity (MFI).
3.4.CorrelationbetweentheIntensityofPreoperativeCholesta-
sis and Presence of Perforin-Expressing Cells. The ﬁndings
of the marked changes in the proportions and MFI of
perforin-expressing cells in preoperative blood suggested
that these events might be related with the previously
described greater cholestasis and inﬂammation in patients
elected for classic cholecystectomy (Figure 1). To test this
possibility the concentrations of CRP, hepatic enzymes and
bilirubin in preoperative sera of all patients undergoing to
the operations were, individually, in each person correlated
with the percentage of perforin positive cells and with
MFI for perforin in lymphocytes subpopulations found in
preoperative samples of blood.
It was found (Figure 7) that concentration of CRP was
in a very high positive correlation with percentage of total
number of perforin positive cells (r = 0.5218; P<. 002),
CD3+P+ (r = 0.49576; P<. 006) and the fraction of P+ cells
amongCD4+ subsetofcells(r = 0.47551;P<. 006)aswellas
inthenegativecorrelationwiththefractionofP+cells among
CD16+ cells (r =− 0.3752; P<. 041).
The data (Figure 8) revealed also the presence of positive
correlation between the concentration of AP in serum and
proportion of CD4+P+ cells (r = 0.50240; P<. 001) as
well as the presence of negative correlation between AP and
proportion of P+cells among the CD8+cells (r =− 0.3645;
P<. 04), and between the concentration of total bilirubinMediators of Inﬂammation 7
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Figure 6: Representative ﬂow cytometric proﬁle of perforin expression on the gated CD4+ and CD56+ PBMNLC before classic and
laparoscopic cholecystectomy. The shadow area was perforin expression while the nonshadow area was isotype control. The amount of
perforin per cell is indicated by the mean ﬂuorescence intensity.
and proportion of P+ cells in CD8+ cells (r =− 0.3655;
P<. 034).
However, although these data suggested that cholesta-
sis and inﬂammation have induced a switch in immune
response toward the CD4+P+cells, it was also found that
higher concentrations of ALT in sera increased the MFI of
perforin in CD16+ (r = 0.409; P<. 016) and CD56+cells
(r = 0.509; P<. 002), suggesting that remaining NK cells,
owing to the increased content of P probably obtained a
higher cytotoxic activity (Figure 9).
4. Discussion
Tryingtocontributetotheelucidationofprofoundimmuno-
logical dysfunctions induced by surgical trauma [1–11]a n d
mechanisms that regulate the P expression in cytolytic cells
[12–15], in this study we analyzed primarily the changes in
perforin expressing peripheral blood lymphatic cells after
OC and LC. The data showed that in early postoperative
period, the type of operation minimally aﬀected the P-
related events, since only LC decreased the percentage of8 Mediators of Inﬂammation
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Figure 7:Correlation(r)betw eenpr eoperati v eserumlev elsofC-r eacti v epr ot ein(CRP)andt otaln umberofperforinpositi v ec ells,CD3 +P+
cells and fraction of perforin positive (P+) cells among CD4+ Tc e l l s ,C D 8 + Tc e l l so rC D 1 6 +NK cells in preoperative samples of blood.
circulating CD8+P+cells (Figures 3(a), 3(c)) and increased
the MFI of perforin in CD56+cells (Figures 5(b), 5(c)),
suggesting that the pneumoperitoneum with insuﬄations
of CO2 had a stimulating eﬀect on cytolytic activity of
NK cells and contributed to distribution of CTL in the
tissue. Changes might be related with lower operative
stress, extracellular acidiﬁcation or selective activation of
diﬀerentmacrophagesubpopulation[1–11]butneedfurther
characterization, particularly, owing to our ﬁndings that
immune outcome of cholecystectomy might be markedly
inﬂuenced by the intensity of preoperative inﬂammation
and cholestasis. In our study this, obviously, inﬂuenced
the number of perforin expressing cells in both groups of
patients since they, preoperatively, had signiﬁcantly lower
proportions of CD16+P+ and CD56+P+ cells (Figures 3(b)
and 4(b)). Similarly, augmented proportions of TP+ cells,
CD3+P+ cells and CD4+P+ cells (Figures 3(a) and 4(a))
were found in patients elected for OC, which preoperatively,
had higher preoperative levels of CRP, AP, B, AST and
ALT (Figure 1), suggesting that preoperative inﬂammation
and cholestasis aﬀected the perforin-related events. The
hypothesiswasconﬁrmedbylinearregressionanalyses,made
in all patients elected for the operations, which clearly
showed that the concentration of CRP in the serum was in
high positive correlation with the percentage of TP+ cells,
CD3+P+ and CD4+P+ cells and in negative correlation with
thefractionofP+ cellsamongtheCD16+ NKcells(Figure 7).
Moreover, an additional eﬀect of cholestasis was conﬁrmed
by ﬁnding of positive correlation between AP in the serum
and fraction of CD4+P+ cells, and negative correlation of
both AP and bilirubin with fraction of P+ cells among
CD8+ cells (Figure 8). Taken together, the data imply that,
in patients with gallstones, the inﬂammation and chronic
cholelithiasis had particularly stimulated the generation
of cytotoxic CD4+P+ cells, decreasing simultaneously the
circulating levels of CD8+P+ T cells and CD16+P+NK cells
(Figures 3, 4, 6,a n d7), probably owing to their greater
homing into the insulted liver tissue. However, based on the
fact that ALT was in high positive correlation with MFI of
perforin in CD16+ and CD56+cells (Figure 9), we speculated
also that hepatic injury might increased the content of
perforin per cell in remaining circulating NK cells.Mediators of Inﬂammation 9
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Figure 8: Correlation (r) between preoperative serum levels of alkaline phosphatase (AP) and total bilirubin and the proportion of
CD4+P+cells or fraction of perforin positive (P+) cells inside the CD8+ subpopulation of T cells, respectively.
The data are in high agreement with current knowledge
about the inﬂuence of inﬂammation and injuries on cyto-
toxic cells of innate [18, 19] and adaptive immunity [20, 21]
and point to the liver as an important organ for maintenance
of self-tolerance and elimination of potentially dangerous
cells that arose during the cholestasis and hepatic damages
in patients with gallstones. The mechanisms are unclear,
since the consequences of obstructive jaundice are complex
and involve a number of immune eﬀectors that contribute
to a variety of immunological derangements [22, 23]a s
well as to hepatic regeneration [24, 25]a n dﬁ b r o s i s[ 26].
In this context it could be speculated that destruction
of intrahepatic bile ducts or the appearance of aberrant
cholangiocytes has initially stimulated the intrahepatic NK
cells, leading to cholangiocyte killing and apoptosis by
the granzyme/perforin pathway or by activation of death
receptors belonging to the tumor necrosis factor (TNF)
receptor superfamily and TRAIL, as it was reported in the
bile duct-ligated mice [27] and in patients with the primary
biliary cirrhosis, where the activation of hepatic NK cells led
to exacerbated damage on liver tissues [23, 28, 29]. Note-
worthy,highercytotoxicitymightbeinducedbyactivationof
severalclassesofkillerlectin-likereceptors(e.g.,NKG2Dand
natural cytotoxicity receptors), that are commonly expressed
by human NK cells as well as by TCRγδ+and TCRαβCD8+
T lymphocytes and speciﬁcally interact with stress-inducible
molecules, such as MICA, MICB, and ULBP, which might be
displayed by “stressed” or “altered” self cells and by virus-
infected cells [30]. Furthermore, since cholestatic jaundice is
often followed by bacteriemia [22, 23], for our data showing
the correlation of CD4+P+ cells with the serum levels of
CRP and AP (Figures 7 and 8) might be relevant that
in inﬂammatory bowel diseases with uncontrolled immune
responses to bacterial ﬂora were found CD4 (+) NKG2D (+)
T-cell clones that were involved in perforin-mediated killing
of the targets expressing MICA [31].10 Mediators of Inﬂammation
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Figure 9: Correlation (r) between preoperative serum level of alanine aminotransferase (ALT) and average ﬂuorescence intensity (AFI) of
perforin in CD16+ and CD56+ NK cells.
It should be, however, emphasized that CD4+P+ cells T
cells, activated in the liver, might belong also to CD4+NKT
cells or to CD4+CD25+ regulatory T cells, since these autore-
active T cells clones also participate in perforin-mediated
killing. The former, which might be activated by glycolipid
antigens, are characterized also by rapid activation and
secretion of large amounts of numerous types of cytokines
that in turn interact with a multitude of other cell types
[32–35], while the latter are known to participate in the
control of autoantigen recognition and the development
of autoreactive T cells clones, by mechanisms that include
direct killing of cytotoxic cells through cell-to-cell contact,
inhibition of cytokine production by cytotoxic cells and
direct secretion of immunomodulatory cytokines, such as
TGF-β and interleukin-10 [36–39], acting together with
other CD4+ cells as crucial regulators of adaptive and innate
immune responses [40].
In conclusion, our data show that in early postop-
erative period only laparoscopic cholecystectomy moder-
ately aﬀected perforin-expressing cells in peripheral blood,
decreasing the percentage of CD8+P+ cells and increasing
the content of perforin in CD56+ cells. However, pointing to
the complexity of physiological and immunological derange-
ments induced by cholelitiasis and obstructive jaundice, we
also show that preoperative cholestasis and hepatic injury,
might have a marked inﬂuence on perforin-related aspects
of cytotoxic T and NK cells and ﬁnal interpretation of data
obtained by classic or laparoscopic cholecystectomy.
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